Pfizer CEO Ian Read on Sunday described the company's new proposal for AstraZeneca as "compelling" and cautioned that the American drugmaker would walk away if AstraZeneca didn't accept it.

Pfizer's takeover bid for AstraZeneca is not inevitable and the Anglo-Swedish pharmaceutical giant can create value for its shareholder on its own, according to AstraZeneca CEO Pascal Soriot's claims.

Amid ongoing political storm over Pfizer's potential takeover of British pharmaceuticals giant AstraZeneca, some analysts have pointed out that AstraZeneca is apparently not British.

Governors of Delaware and Maryland have expressed their concerns over the impact of Pfizer Inc.'s proposed takeover of British pharmaceuticals giant AstraZeneca on workers as well as the states' economies.

British lawmakers are concerned about the future of AstraZeneca and thousands of its employees, as U. S.-based pharmaceuticals giant Pfizer is preparing a £60 billion (nearly $100bn) takeover bid for the British firm.

The potential takeover of British pharmaceuticals firm AstraZeneca by American drugs giant Pfizer has raised concerns about the future of British firm's employees.